Results 271 to 280 of about 150,656 (304)

Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial Infarction

New England Journal of Medicine, 1984
Keith A A Fox
exaly  

Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year

New England Journal of Medicine, 1999
Mei Lu, Joseph P Broderick, Thomas G Kwiatkowski   +2 more
exaly  

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

Lancet, The, 1993
exaly  

Tissue Plasminogen Activator for Acute Ischemic Stroke

New England Journal of Medicine, 1995
Steven Wolf
exaly  

SPECIFIC LYSIS OF AN ILIOFEMORAL THROMBUS BY ADMINISTRATION OF EXTRINSIC (TISSUE-TYPE) PLASMINOGEN ACTIVATOR

Lancet, The, 1981
exaly  

Recombinant tissue plasminogen activator

Reactions, 1986
openaire   +1 more source

ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction

Lancet, The, 1992
exaly  

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

Lancet, The, 2012
Peter Sandercock, Joanna M Wardlaw, Richard I Lindley   +2 more
exaly  

Tissue‐type Plasminogen Activator

2008
openaire   +2 more sources

[Tissue plasminogen activator].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 1985
openaire   +1 more source